Home > Insider Trading > Arbutus Biopharma Corp

Arbutus Biopharma Corp (ABUS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Arbutus Biopharma Corporation (NASDAQ:ABUS) Q4 2022 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Corporation Fourth Quarter and Year-End 2022 Financial Results and Corporate Update Conference Call.

Keep Reading →

March 6th, 2023 - News Transcripts

5 Penny Stocks With Biggest Upside

Denison Mines Corp. (NYSE:DNN) engages in the acquisition, exploration, development, extraction, processing, selling off, and investing of uranium properties in Canada.

Keep Reading →

December 20th, 2022 - Hedge Funds News

5 Best High Volume Penny Stocks to Buy Now

Arbutus Biopharma Corporation (NASDAQ:ABUS) is a biopharmaceutical company that develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United...

Keep Reading →

November 3rd, 2022 - Hedge Funds News

5 Penny Stocks to Buy in March

CTI BioPharma Corp. (NASDAQ:CTIC) is a biopharmaceutical company based in the United States, developing therapies for blood-related cancers.

Keep Reading →

March 7th, 2022 - Hedge Funds News

5 Penny Stocks Most Popular on Reddit and Robinhood

In this article, we discuss the 5 penny stocks most popular on Reddit and Robinhood.

Keep Reading →

December 12th, 2021 - Hedge Funds News

5 Penny Stocks to Buy in December

Daré Bioscience, Inc. (NASDAQ:DARE) is a clinical-stage biopharma firm focusing on products related to the health of women.

Keep Reading →

December 11th, 2021 - Hedge Funds News

Hedge Fund and Insider Trading News: Maso Capital, Engine Capital, Cinctive Capital Management, Millennium Management, Third Point LLC, Elliott Advisors, Arbutus Biopharma Corp (ABUS), Opendoor Technologies Inc (OPEN), and More

Maso Capital, an event driven and convertible arbitrage-focused hedge fund based in Hong Kong, was established in 2012 by Manoj Jain and Sohit Khurana, who previously managed money for Och-Ziff’s Asia...

Keep Reading →

December 6th, 2021 - Hedge Funds Insider Trading

5 Best Biotech Stocks Under $5

NuCana plc (NASDAQ:NCNA) is a UK-based biotech company focused on discovering treatments for different types of cancer.

Keep Reading →

November 14th, 2021 - Hedge Funds News

5 Penny Stocks With Long-Term Growth Catalysts

In this article, we discuss the 5 penny stocks with long-term growth catalysts.

Keep Reading →

October 4th, 2021 - Hedge Funds News

Is ABUS A Good Stock To Buy Now?

With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth ...

Keep Reading →

December 12th, 2020 - Hedge Funds News